Anti-cd30l antibodies and uses thereof
CR20260139APending Publication Date: 2026-06-18AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CR202600139
- Authority / Receiving Office
- CR · CR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-10
- Filing Date
- 2024-09-10
- Publication Date
- 2026-06-18
Abstract
This disclosure provides anti-CD30L antibodies and methods for manufacturing and using such anti-CD30L antibodies.
Need to check novelty before this filing date? Find Prior Art